David Siegel, M.D., M.P.H.
Title
Chief of Medicine
Professor and Vice Chair of Medicine, University of California, Davis
Veterans Administration Northern California Health Care System
Specialty
Infectious Diseases, Internal Medicine
Department
Internal Medicine
Division
General Medicine
Select Recent Publications
Devaraj S, Jialal G, Cook T, Siegel D, Jialal I. Low vitamin D levels in northern american adults
with the metabolic syndrome. Horm Metab Res 2011;43:72-74.
Devaraj S, Siegel D, Jialal I. Post-JUPITER: statin therapy in metabolic syndrome and hypertension:
value of CRP. Curr Atheroscler Rep 2011;13:31-42.
Garcia EA, Lopez J, Meier J, Swislocki A, Siegel D. Resistant hypertension and undiagnosed
primary hyperaldosteronism detected by use of a computerized database. J Clin Hypertens
(Greenwich) 2011;13:487-91.
Siegel D, Swislocki A. The ACCORD study: the devil is in the details. Met Syndr Relat Disord 2011;
9:81-84.
Siegel D, Swislocki A. Treatment of hypertesnion in patients with the metabolic syndrome Met
Syndr Relat Disord 2010;8:95-104.
Devaraj S, Valleggi S, Siegel D, Jialal I. Role of c-reactive protein in contributing to increased
cardiovascular risk in metabolic syndrome. Curr Atheroscler Rep 2010;12:110-118.
Kelley DS, Siegel D, et al. Docosahexaenoic acid supplementation decreases serum C-reactive
protein and other markers of inflammation in hypertriglyceridemic men. J Nutr 2009;139:495501.
Seeley A, Lopez J, Meier J, Swislocki A, Siegel D. The effect of body mass index on fasting blood
glucose and development of diabetes mellitus after initiation of extended release niacin. Met Syndr
Relat Disord 2009;8:79-84.
Swislocki A, Noth RH, Volpp B, Meier J, Siegel D. Computer confirmation of improved blood
pressure control in diabetic patients. Preventive Cardiol 2009;12:149-154.
Siegel D, Meier J, Maas C, et al. The effect of body mass index on fasting blood glucose after
initiation of thiazide therapy in hypertensive patients. Amer J Hypertens 2008;21:438-42.
Kelley DS, Siegel D, Vemuri M, et al. Docosahexaenoic acid supplementation decreases remnantlike particle-cholesterol and increases the (n-3) index in hypertriglyceridemic men. J Nutr 2008;
138:30-35.
David Siegel, M.D., M.P.H.
Singh U, Deveraj S, Jialal I, Siegel D. Comparison Effect of Atorvastatin (10 mg versus 80 mg) on
Biomarkers of Inflammation and Oxidative Stress in Subjects with the Metabolic Syndrome. Am J
Cardiol 2008;102:321-325.
Kelley DS, Siegel D, Vemuri M, et al. Docosahexaenoic acid supplementation improves fasting and
postprandial plasma lipid profiles in hypertriglyceridemic men. Am J Clin Nutr 2007;86:324-33.
Siegel D, Lopez J, Meier J. Antihypertensive medication adherence in the Department of Veterans
Affairs. Amer J Med 2007;120:26-32.
Deveraj S, Siegel D, Jialal, I. Simvastatin (40 mg), adiponectin levels, and insulin sensitivity in
subjects with the metabolic syndrome. Amer J Cardiol 2007;100:1397-1399.
Siegel D, Swislocki AJM. Effects of antihypertensives on glucose metabolism. Met Syndr Relat
Disord 2007;5:211-219.
© 2016 UC Regents